The Capital Markets department represented Aegis Capital Corp. as Lead Placement Agent in an approximately $5 million concurrent registered direct and private placement offering of ordinary shares, debentures and warrants by Rosetta Genomics and in an approximately $12.3 million public offering of common stock by Rennova Health Inc.
In addition the department represented Roth Capital Partners as lead placment Agent in an approximately $5 million sale of convertible notes by Top Image Systems to Hale Capital Partners LP. and in approximately $8.5 public offering by Light Path Technologies.
